card-3216_Biochemistry expert scientific with eyeglasses
Digital innovation

Driving operational improvements and quality of our services

card-3210_Laboratory technicians conduct a series of tests on a chemical analyzer
Science Innovation

Uniquely positioned to shape, validate, and deliver biomarker assessments that strive to improve patient outcomes across diverse Therapeutic Areas

card-3242_Scientist using tablet while colleagues working behind
Download our Corporate brochure

We are IQVIA Laboratories, a leading clinical trial laboratory services organization with end-to-end laboratory services and secure, enterprise-wide biospecimen and consent management solutions.

Download
card-3233_Laboratory scientist working at lab with micropipette, and 96 well plate
Corporate Video

Our commitment to customer success is embedded in every facet of our operations.

card-3210_Laboratory technicians conduct a series of tests on a chemical analyzer
Science Innovation

Uniquely positioned to shape, validate, and deliver biomarker assessments that strive to improve patient outcomes across diverse Therapeutic Areas

card-3216_Biochemistry expert scientific with eyeglasses
Digital Innovation

Driving operational improvements and quality of our services

English You are about to exit for another IQVIA country or region specific website Please be aware that the website you have requested is intended for the residents of a particular country or region, as noted on that site. Ok Open in new tab Search
hero-bg-3210_Laboratory technicians conduct a series of tests on a chemical analyzer

TruSight Oncology 500 ctDNA(TSO500 ctDNA)

Minimally invasive, pan-cancer next-generation sequencing assay for biomarker identification and comprehensive genomic profiling across 523 genes

A Hybrid-Capture Approach for Target Enrichment of 523 Genes Across Various Tumor Types​

Gain an expansive view of your liquid biopsy samples by targeting 523 cancer-related genes using the TruSight Oncology 500 ctDNA assay. Not only does this assay identify all relevant variants (DNA fusions, SNVs, CNVs, insertions, and deletions) across various tumor types, but it also reports tumor mutational burden (TMB) and microsatellite instability (MSI) scores.

 

Our comprehensive genomic panel has advantages over individual biomarker assays in its ability to detect multiple biomarkers with one test, saving time, money, and samples. IQVIA Laboratories can meet your profiling needs by leveraging trusted technology from Illumina® in combination with our global laboratory network and expert support team.

3239_A row of human blood samples in a medical laboratory ready to be tested

An Efficient, Reliable Solution for Non-Invasive Tumor Characterization

minimal-sample-red

Minimal input, extensive results

Obtain full exon coverage of 522 out of 523 genes using as little as 3 mL of plasma, 20-30 ng of cfDNA, or 10 mL of whole blood. TSO500 ctDNA can detect biomarkers without the need of a matched normal sample.

workflow-savings-red

Simple, cost-effective workflow

Detect multiple biomarkers with a single assay to save time, money, and samples. The distributable kit enables global implementation.

precision-red

Confident variant detection

Obtain a high-resolution view of variants enabled by TSO500 ctDNA’s hybrid-capture chemistry and unique molecular indices (UMIs).

measure-dna-red

Measurement of key immuno-oncology biomarkers

Gain insight into TMB score and MSI score in addition to variant calls. TruSight Oncology 500 ctDNA can reproducibly assess TMB.

global-network-red

Expansive services enabled by our global network

Our centralized, scientific operational oversight combined with our global laboratory footprint enable comprehensive, large-scale trial support. We enable clinical development support irrespective of geography.

flexible-filter-red

Flexible customization to satisfy specific needs

We work with you to understand your specific needs, and our team provides cost-effective recommendations from custom assay development to specialized bioinformatics support.

TSO500 ctDNA Variant Detection

 

red-helix-tso500

TSO500 Assay Comparison

 

layered-circles_edited-text-size_rev07172023
Request a quote

Deep Sequencing Enabled by IQVIA's Subject Matter Expertise

Feel confident in your results with the trusted Illumina® software pipeline. Our software teams validate the most up-to-date software to ensure you are receiving optimal results. IQVIA Laboratories can develop custom reporting and filtering to meet your specific research needs. IQVIA Laboratories was one of the earliest adopters of DRAGEN™. Our technical support teams help you understand your deep sequencing data with our superior bioinformatics knowledge.

3235_Pipetting robot laboratory

Deliverables

IQVIA Laboratories provides a text-delimited, combined variant output file for all biomarkers

  • QC Metrics​
  • CNV Outputs​
  • DNA Fusion Report​
  • Genomic VCFs (SNVs & Indels)​
  • Variant Call Annotations
  • MSI Scores​
  • TMB Scores​
  • FASTQs Upon Request​
  • BAMs Upon Request

Supporting Studies Around the World 

Our centralized, scientific, and operational oversight combined with our global laboratory footprint enables comprehensive, large-scale trial support. You will be supported every step of the way by our scientific project management team who will work with you to understand the most cost-effective recommendations to meet your specific needs. We are committed to transparency so you can feel confident in our promises of quality and timely delivery. We can expert support team can meet your research needs from nearly anywhere in the world with our genomic centers in the United States, China, United Kingdom, and Singapore.

genomics-map-v07172023

Learn More About TSO500 with IQVIA

Simplify Your Work

8-2-3-4_red

Request a Quote

Request a quote today to discover how TSO500 with IQVIA can advance your research.

Ship Samples

Ship your samples to one of our global genomic laboratory centers.​

Get Results

Obtain in-depth data revealing insights into your solid tumor samples.

Request a quote

Related Services

card-3233_Laboratory scientist working at lab with micropipette, and 96 well plate

Clinical Genomics Laboratory Services

Learn more
card-3215_People working at laboratory

Next Generation Sequencing Services

Learn more
card-3270_young woman scientist in laboratory working

Microsatellite Instability (MSI) Assay

Learn more
card-3241_Technician holding blood tube test in the research laboratory

Immune Landscape Signatures

Learn more
card-3256_scientist team meeting

Tumor Mutational Burden (TMB) Analysis

Learn more
card-3223_Nurse standing in a laboratory and taking test tubes with blood samples

TruSight Oncology 500 Plasma Assay

Learn more
card-3256_scientist team meeting

Tumor Mutational Burden (TMB) Analysis

Learn more
card-3233_Laboratory scientist working at lab with micropipette, and 96 well plate

RNA Sequencing and DNA Sequencing Services

Learn more
card-3223_Nurse standing in a laboratory and taking test tubes with blood samples

Clinical Genomics Laboratory Technology Platforms

Learn more
card-3235_Pipetting robot laboratory

Bioinformatics

Learn more
card-3275_Young scientist works in modern laboratory

Central Laboratory Services

Learn more

Related Insights

Reproducibility Challenges in an era of Massive Data

Presented at the MCBIOS & MAQC 2021 Joint Conference

A Verified Genomic Reference Sample for Assessing Performance of Cancer Panels Detecting Small Variants of Low Allele Frequency

Presented at the MCBIOS & MAQC 2021 Joint Conference

Unexpected Impacts to Library Complexity After DNA and RNA Library Preparation in Illumina Next Generation Sequencing

Presented at the MCBIOS & MAQC 2021 Joint Conference

Immune Landscape Signatures for Characterization of Tumor Microenvironment and Response to Therapy

Gene expression and analysis for detection of 38 Immune Landscape Signatures

Using Gene Signature Methodologies to Strengthen Immuno-Oncology Trials

Genomic technologies that empower and enhance immuno-oncology trials

Laboratory Solutions for Hepatitis B (HBV) Clinical Trials

Insight brief by Joseph Sebastian, Ph.D., Scientific Advisor, Infectious & Liver Diseases

Enabling blood sample prep for single cell sequencing in clinical research

The Role of Genomics in Clinical Trials with Patrick Hurban

I-O clinical development podcast series

IQVIA Laboratories Corporate Brochure

Learn about what we do and our commitment to innovation

Evaluating and Implementing SARS-CoV-2 PCR Tests for Diagnostic and Clinical Trial Use

AAPS 2020 COVID-19 Workshop: Current Pharmaceutical Developments for Cures and Prevention

See All